Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. UPLOAD Other SEC-generated Letter
  2. 425 Deal Prospectus/Communication re Business Combination
  3. S-4 Deal Registration Statement - Business Combination
  4. 8-K Event Material agreement
  5. 425 Deal Prospectus/Communication re Business Combination
  6. SC 13D Stake Beneficial Ownership Report
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 425 Deal Prospectus/Communication re Business Combination
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 4 Insider Changes in Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 10-Q Report Quarterly Report
  15. 4 Insider Changes in Ownership
  16. 425 Deal Prospectus/Communication re Business Combination
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 425 Deal Prospectus/Communication re Business Combination
  19. 425 Deal Prospectus/Communication re Business Combination
  20. 425 Deal Prospectus/Communication re Business Combination

Page 29 of 45 · 886 filings